B BEGIN Trademark

Trademark Overview

On Tuesday, October 9, 2018, a trademark application was filed for B BEGIN with the United States Patent and Trademark Office. The USPTO has given the B BEGIN trademark a serial number of 88148129. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 18, 2021. This trademark is owned by GlaxoSmithKline Consumer Healthcare (US) IP LLC. The B BEGIN trademark is filed in the Pharmaceutical Products category with the following description:

Gastro-intestinal treatment preparations; therapeutic agents for weight control and appetite suppression; vitamins, mineral supplements and food supplements
b begin

General Information

Serial Number88148129
Word MarkB BEGIN
Filing DateTuesday, October 9, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 18, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 21, 2020

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of a lower case letter "B" with the word "BEGIN" in the straight part of the letter with an arrow device curved and pointing to the right of the image at the top. Within the arrow device is a circle.
Goods and ServicesGastro-intestinal treatment preparations; therapeutic agents for weight control and appetite suppression; vitamins, mineral supplements and food supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 18, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Consumer Healthcare (US) IP LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808
Party NameGlaxoSmithKline Consumer Healthcare (US) IP LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWilmington, DE 19808

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 18, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 16, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, June 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 21, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 20, 2020LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, July 29, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 29, 2019LETTER OF SUSPENSION E-MAILED
Monday, July 29, 2019SUSPENSION LETTER WRITTEN
Saturday, July 6, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 5, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 9, 2019NON-FINAL ACTION E-MAILED
Wednesday, January 9, 2019NON-FINAL ACTION WRITTEN
Tuesday, November 27, 2018EXAMINER'S AMENDMENT ENTERED
Tuesday, November 27, 2018ASSIGNED TO LIE
Tuesday, November 27, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 27, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, November 27, 2018EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 27, 2018ASSIGNED TO EXAMINER
Friday, October 19, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, October 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, October 12, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

begin supplements suppression appetite vitamins mineral food control weight treatment intestinal